Agentix (AGTX) Net Cash Flow (2013 - 2026)
Agentix's (AGTX) quarterly Net Cash Flow came in at $14776.0 in Q1 2026, up 660.87% YoY from $1942.0 in Q1 2025, and up 583.44% on a QoQ basis from $2162.0 in Q4 2025.
Agentix (AGTX) Net Cash Flow (2013 - 2026) Analysis & Trends
Agentix (AGTX) has 14 years of Net Cash Flow data on file, last reported at $14776.0 in Q1 2026.
- Quarterly Net Cash Flow rose 660.87% year-over-year to $14776.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1921.0 (up 107.66% YoY) and the FY2026 annual result came in at $1921.0, up 107.66% from the prior year.
- Net Cash Flow improved to $14776.0 in Q1 2026, from $2162.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $17600.0 in Q2 2024 to a low of -$61999.0 in Q4 2024.
- A 5-year average of -$1820.4 and a median of $2337.5 in 2022 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 6251.98% in 2023, down 29102.27% in 2023.
- Tracing AGTX's Net Cash Flow over 5 years: stood at $202.0 in 2022, then surged by 6251.98% to $12831.0 in 2023, then slumped by 583.2% to -$61999.0 in 2024, then soared by 103.49% to $2162.0 in 2025, then surged by 583.44% to $14776.0 in 2026.
- The last three Net Cash Flow figures came in at $14776.0 (Q1 2026), $2162.0 (Q4 2025), and $3354.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -496,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -37.14 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 225.59 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -2.83 Bn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | -122.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -122.00 |
| Jun 30, 2026 | -122.00 |
| Mar 31, 2026 | 14,776.00 |
| Mar 31, 2026 | 14,776.00 |
| Dec 31, 2025 | 2,162.00 |
| Dec 31, 2025 | 2,162.00 |
| Sep 30, 2025 | 3,354.00 |
| Sep 30, 2025 | 3,354.00 |
| Jun 30, 2025 | -18,371.00 |
| Jun 30, 2025 | -18,371.00 |
| Mar 31, 2025 | 1,942.00 |
| Mar 31, 2025 | 1,942.00 |
| Dec 31, 2024 | -61,999.00 |
| Dec 31, 2024 | -61,999.00 |
| Sep 30, 2024 | 17,379.00 |
| Sep 30, 2024 | 17,379.00 |
| Jun 30, 2024 | 17,600.00 |
| Jun 30, 2024 | 17,600.00 |
| Mar 31, 2024 | -23,197.00 |
| Mar 31, 2024 | -23,197.00 |